Press releases
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- Prothena to Report First Quarter 2024 Financial Results on May 8
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
- Prothena to Participate in Upcoming Healthcare Conferences
Key statistics
On Friday, Prothena Corporation PLC (0Y3M:LSE) closed at 20.12, 1.51% above its 52-week low of 19.82, set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 20.08 |
Average volume | 87.80 |
---|---|
Shares outstanding | 53.77m |
Free float | 47.09m |
P/E (TTM) | -- |
Market cap | 1.08bn USD |
EPS (TTM) | -3.25 USD |
Data delayed at least 20 minutes, as of May 24 2024 17:07 BST.
More ▼